Neogenix to initiate clinical trial of monoclonal antibodies for colorectal and pancreatic cancer Dec. 15, 2008
Epigenomics presents update on PRESEPT clinical study of Septin 9 biomarker in colorectal cancer Oct. 28, 2008
FDA grants regulatory clearance to Response Biomedical to market Ramp NT-proBNP test for HF July 25, 2008
RSS